You just read:

Merrimack Announces Acceptance for Review of ANDA filed by Actavis for Generic Doxorubicin Hydrochloride Liposome Injection (aka DOXIL®)

News provided by

Merrimack Pharmaceuticals, Inc.

Oct 31, 2016, 07:30 ET